lactose has been researched along with methadone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Andresen-Streichert, H; Elakkary, S; Heinemann, A; Iwersen-Bergmann, S; Jungen, H; Müller, A; Püschel, K | 1 |
| Andresen-Streichert, H; Iwersen-Bergmann, S; Jungen, H; Müller, A | 1 |
| Crowley, M; Ford, S; Kaplan, HC; Kuhnell, P; Lannon, C; Macaluso, M; McClead, R; Provost, LP; Walsh, MC; Wexelblatt, S | 1 |
4 other study(ies) available for lactose and methadone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Intravenous methadone application as a serious risk factor for an overdose death: methadone-related fatalities in Hamburg from 2007 to 2012.
Topics: Adult; Buprenorphine; Drug Overdose; Female; Forensic Toxicology; Germany; Humans; Lactose; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Risk Factors; Substance Abuse, Intravenous; Sucrose | 2014 |
Monitoring Intravenous Abuse of Methadone or Buprenorphine in Opiate Maintenance Treatment (OMT): A Simple and Fast LC-MS-MS Method for the Detection of Disaccharides in Urine Samples.
Topics: Adult; Biomarkers; Buprenorphine; Carbonated Beverages; Case-Control Studies; Chocolate; Chromatography, Liquid; Female; Humans; Lactose; Limit of Detection; Male; Methadone; Middle Aged; Opiate Alkaloids; Reproducibility of Results; Substance Abuse Detection; Substance Abuse, Intravenous; Sucrose; Tandem Mass Spectrometry; Young Adult | 2017 |
Orchestrated Testing of Formula Type to Reduce Length of Stay in Neonatal Abstinence Syndrome.
Topics: Energy Intake; Female; Humans; Infant Formula; Infant, Newborn; Lactose; Length of Stay; Methadone; Morphine; Neonatal Abstinence Syndrome; Ohio; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Quality Improvement; Weight Gain | 2020 |